An understanding of the neurobiological mechanisms involved in the regulation of fear is essential for the development of new treatments for anxiety disorders, such as phobias, panic, and post-traumatic stress disorders (PTSD). Orexins, also known as hypocretins, are neuropeptides located exclusively in hypothalamic neurons that have extensive projections throughout the central nervous system. Although this system was initially believed to be primarily involved in the regulation of feeding behavior, recent studies have shown that orexins also modulate neural circuits implicated in the expression and extinction of fear memories. Here, we discuss recent findings involving orexins in anxiety disorders and current clinical trials using orexin ligands that could be applied to identify new therapies for diseases characterized by pathological fear.
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General overview of the orexin system
The orexin system comprises two neuropeptides, orexin A and B (also known as hypocretin 1 and 2), and their associated G protein-coupled orexin type 1 (OX1R) and 2 (OX2R) receptors [1, 2] . Orexin A and orexin B are 33-and 28-amino acid peptides, respectively, produced by the proteolysis of a common precursor, prepro-orexin. Radioligand-binding assays have demonstrated that orexin B binds preferentially to OX2R, whereas orexin A binds with equal affinity to OX1R and OX2R [1] . The signal transduction mechanisms triggered upon orexin receptor (OXR) activation mainly involved Gq proteins and the phospholipase C-protein kinase C (PLC-PKC) pathway, although a variety of signals seem to originate from stimulation of these receptors (reviewed in detail in [3] ). Orexin-expressing neurons represent a small population exclusively located in the lateral hypothalamus (LH), the perifornical area (PFA), and the dorsomedial hypothalamus (DMH). Although limited in number and localization, they have extensive projections throughout the brain [4] . OX1R and OX2R have a broad and partially overlapping distribution in many regions of the brain [5] , although some areas have a selective expression of these receptors (Figure 1) .
The widespread projections of the orexin system reflect the variety of physiological functions of orexin peptides, which include: the modulation of arousal and sleep-wake cycles, energy homeostasis, reward processing, and stress (reviewed in [6] [7] [8] ) (Box 1). Moreover, a role for orexins in emotional behavior regulation has been recently proposed, consistent with the existence of orexin neuronal projections to several limbic areas [9] (Figure 1 ) (see Glossary). We review here recent studies involving the orexin system in the modulation of fear memory, and the potential usefulness of orexin ligands to treat trauma and anxietyrelated disorders.
Functional circuitry of fear expression and extinction
Fear is an emotion that is crucial for the organization of defensive behaviors to threat and, therefore, has an Review Glossary Fear-potentiated startle: relative increase in the amplitude of an acoustic startle reflex when elicited in the presence of a neutral CS (e.g., a light) previously paired with an aversive stimulus. Clinically effective anxiolytic drugs decrease or block startle potentiation. Generalized avoidance: maladaptive behavioral response comprising of overinterpretation of contextual cues, leading to generalized fear and exaggerated avoidance of situations that resemble only slightly the context of the initial fearful event. Hypercapnia: abnormally elevated levels of CO 2 in the blood. It is produced by accumulation due to deficient alveolar ventilation. If not restored, this condition leads to an HCO 3 -/CO 2 imbalance and subsequent acidosis (decreased blood pH). Immediate-early gene (IEG): class of genes that respond transiently and rapidly to a variety of extracellular stimuli, such as growth factors and neurotransmitters. These genes usually encode transcription factors that regulate the expression of downstream target genes. The IEGs most commonly used as tools for neuronal activity mapping are c-fos, zif268, and arc. Limbic system: set of functionally and anatomically interconnected brain structures, including, among others, the hypothalamus, HPC, AMY, nucleus accumbens, and cingulate gyrus. They regulate autonomic and endocrine function and set the level of arousal, particularly in response to emotional stimuli. They are also involved in motivation, reward, and memory. Panic disorder: anxiety disorders characterized by sudden and repeated attacks of fear that last for several minutes or longer, which are called panic attacks. During these episodes, the fear response is out of proportion for the situation, which often is not threatening, and physical symptoms may appear, such as sweating and tachycardia. Pavlovian fear conditioning: form of learning in which a neutral stimulus (designated the CS) is paired with an US, which is biologically significant (in this case aversive, e.g., an electrical shock), conveying the association of both stimuli. This results in the expression of fear responses to the originally neutral stimulus or context. Phobia: anxiety disorder characterized by persistent overwhelming and irrational fear of an object or situation that poses little real danger, but provokes anxiety and avoidance. It is long lasting and causes intense physical and psychological reactions, which interfere in social or occupational activities. Post-traumatic stress disorder (PTSD): anxiety disorder that can develop after experiencing or witnessing a traumatic or terrifying event. It is diagnosed when a group of symptoms, such as disturbing recurring flashbacks, avoidance or numbing of memories of the event, and hyperarousal, persist for more than 1 month. 
